Table 4.
Overall Survival (OS)
| Nordlinger | Lorenz | Portier | Langer | Kemeny | Rudroff | Lygidakis | Wagman | |
|---|---|---|---|---|---|---|---|---|
| Median OS time (months) | ||||||||
| Chemotherapy | - | 34.5 | 62.1 | 53 | 34.2 | - | 20 | 37.3 |
| Control | - | 40.8 | 46.4 | 43 | 47.5 | - | 11 | 28.3 |
| OS at last follow-up (cumulative %) | ||||||||
| Chemotherapy | - | - | 51.1 | 57 | 37 | 25 | 95 | - |
| Control | - | - | 41.1 | 47 | 49.3 | 31 | 80 | - |
| Hazard Ratio | - | 1.313 | 0.733 | 0.773 | 1.39 1 | 1.131 | 0.842 | 0.712 |
| SE | - | 0.21 | 0.21 | 0.30 | 0.24 | 0.41 | 0.12 | 0.77 |
| P value | - | 0.15 | 0.13 | 0.39 | 0.19 | 0.77 | < 0.001 | 0.66 |
1 HRs were calculated based on the IPD reconstruction technique
2 only RR could be abstracted
3 HRs were abstracted from original reports